system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, RESULTS. Meshes: Adaptor Proteins, Signal Transducing, Animals, Biomarkers, Tumor, Blotting, Western, Caco-2 Cells, Calcium-Binding Proteins, Carcinoma, Hepatocellular, Electrophoretic Mobility Shift Assay, Endopeptidases, Gene Expression Regulation, Neoplastic, Hepatocyte Nuclear Factor 4, Humans, Immunohistochemistry, Intracellular Signaling Peptides and Proteins, Liver Neoplasms, Liver Neoplasms, Experimental, Mice, Mice, Transgenic, Nuclear Proteins, Phosphoproteins, Promoter Regions, Genetic, Protein Isoforms, RNA Splicing, RNA, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, Ribonucleoprotein, U4-U6 Small Nuclear, Signal Transduction.
user
Are ePS15R , TASP1 , and PRPF3 novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas? Context: The orphan nuclear receptor HNF4alpha is a member of the hepatic transcription factor network. This protein plays a pivotal role in liver development and hepatocellular differentiation. Nine splice variants have been identified, some of which are specifically regulated in disease. The role of HNF4alpha splice variants in hepatocellular carcinomas (HCC) is unknown. Here, we report an identification of novel candidate genes targeted by splice variants of HNF4alpha. We used chromatin immunoprecipitation followed by cloning and sequencing of DNA. Expression of HNF4alpha P1 and P2 promoter-driven isoforms and of genes targeted by HNF4alpha were analyzed by quantitative reverse-transcription polymerase chain reaction, Western blotting, electrophoretic mobility shift assay, and immunohistochemistry. We observed a remarkable switch in gene and protein expression from P1 to P2 promoter-driven fetal isoforms of HNF4alpha in transgenic livers and HCCs of epidermal growth factor (EGF) overexpressing mice and in human HCCs. We further identified EGF-receptor substrate (EPS15R), related EPS15, the premessenger RNA processing factor 3 (PRPF3), and taspase 1 (TASP1) as novel HNF4alpha disease regulated genes with induced expression in mouse and in human HCCs. We suggest EPS15 and EPS15R mediated internalization of activated EGF receptor to result in receptor recycling as to reinforce the proliferative response to EGF. Regulation of the type 2 asparaginase TASP1 and of the splicing factor PRPF3 further documents a switch to fetal liver programs in HCC.
assistant
We report induction of P2 promoter-driven HNF4alpha splice variants and regulation of disease candidate genes in EGF-induced mouse and human HCC. Final Decision: yes